What is Pulse4pulse?
Pulse4pulse is at the forefront of onsite diagnostic testing, specializing in the cardiovascular and autonomic nervous system. The company's core mission is the early detection of chronic diseases in asymptomatic individuals, utilizing state-of-the-art medical devices to diagnose complex symptoms and improve patient adherence to treatment plans. Their comprehensive services address conditions such as peripheral artery disease, hypertension, and diabetic neuropathy, aiming to deliver superior patient care by identifying chronic illnesses before they escalate to require more costly and invasive interventions. The company's commitment to insightful medical reports further enhances its value proposition in preventative healthcare.
How much funding has Pulse4pulse raised?
Pulse4pulse has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Pulse4pulse?
With a substantial late-stage funding context, Pulse4pulse is strategically positioned for significant scaling and market penetration. The recent major strategic investment signals strong confidence from stakeholders in the company's growth trajectory and its innovative approach to chronic disease management. This capital infusion is expected to fuel further development of their diagnostic technologies, expansion of their service offerings, and broader market reach. The company's focus on early detection and preventative care aligns with global healthcare trends, suggesting a robust future for its advanced medical solutions.
See full Pulse4pulse company page
